Tower Research Capital LLC (Trc) Applied Therapeutics Inc. Transaction History

Tower Research Capital LLC (Trc)

$4.87 Billion
Q4 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 24,425 shares of APLT stock, worth $11,479. This represents 0.0% of its overall portfolio holdings.

Number of Shares

24,425

Previous 532 4491.17%

Holding current value

$11,479

Previous $4,000 400.0%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$0.82 - $10.24 $19,592 - $244,664	23,893 Added 4491.17%	24,425 $20,000
Q3 2024 Nov 14, 2024	BUY	$4.35 - $8.5 $2,314 - $4,522	532 New	532 $4,000
Q1 2024 May 15, 2024	SELL	$2.25 - $7.4 $29,056 - $95,563	-12,914 Reduced 55.72%	10,261 $69,000
Q4 2023 Feb 13, 2024	SELL	$1.84 - $3.35 $22,573 - $41,097	-12,268 Reduced 34.61%	23,175 $77,000
Q3 2023 Nov 14, 2023	BUY	$1.26 - $2.77 $35,233 - $77,457	27,963 Added 373.84%	35,443 $88,000
Q2 2023 Aug 14, 2023	BUY	$0.77 - $1.8 $517 - $1,209	672 Added 9.87%	7,480 $9,000
Q1 2023 May 09, 2023	BUY	$0.75 - $1.21 $1,297 - $2,093	1,730 Added 34.07%	6,808 $6,000
Q4 2022 Feb 10, 2023	SELL	$0.54 - $1.12 $2,898 - $6,012	-5,368 Reduced 51.39%	5,078 $4,000
Q3 2022 Nov 10, 2022	SELL	$0.86 - $1.55 $184 - $333	-215 Reduced 2.02%	10,446 $10,000
Q2 2022 Aug 15, 2022	BUY	$0.76 - $2.64 $3,647 - $12,669	4,799 Added 81.87%	10,661 $10,000
Q1 2022 May 12, 2022	BUY	$1.48 - $6.22 $2,357 - $9,908	1,593 Added 37.32%	5,862 $13,000
Q4 2021 Feb 14, 2022	BUY	$8.77 - $18.29 $27,686 - $57,741	3,157 Added 283.9%	4,269 $38,000
Q3 2021 Nov 15, 2021	SELL	$13.54 - $22.06 $4,671 - $7,610	-345 Reduced 23.68%	1,112 $18,000
Q2 2021 Aug 16, 2021	SELL	$14.05 - $25.04 $4,243 - $7,562	-302 Reduced 17.17%	1,457 $31,000
Q1 2021 May 17, 2021	BUY	$16.57 - $28.65 $381 - $658	23 Added 1.32%	1,759 $33,000
Q4 2020 Feb 16, 2021	SELL	$15.44 - $24.23 $176,232 - $276,561	-11,414 Reduced 86.8%	1,736 $38,000
Q3 2020 Nov 16, 2020	BUY	$19.43 - $35.36 $202,888 - $369,229	10,442 Added 385.6%	13,150 $273,000
Q2 2020 Aug 13, 2020	BUY	$29.41 - $51.23 $79,642 - $138,730	2,708 New	2,708 $98,000
Q1 2020 May 15, 2020	SELL	$19.54 - $55.47 $15,475 - $43,932	-792 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$10.16 - $28.14 $8,046 - $22,286	792 New	792 $22,000
Q3 2019 Nov 05, 2019	SELL	$8.08 - $10.99 $3,991 - $5,429	-494 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$8.1 - $10.05 $4,001 - $4,964	494 New	494 $4,000

Others Institutions Holding APLT

# of Institutions

130

Shares Held

112M

Call Options Held

1.1M

Put Options Held

800K

View Full List

About Applied Therapeutics Inc.

Ticker APLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,700
Market Cap $22.6M
Description
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...

More about APLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Applied Therapeutics Inc. Transaction History